{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:33:17Z","timestamp":1787157197521,"version":"build-2736575974"},"reference-count":64,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Photoreceptors work in a biologically demanding compartment of the eye. They consume large amounts of energy, receive continuous light and oxygen, and renew outer-segment membranes enriched in polyunsaturated lipids. These conditions are necessary for vision, but they also make the outer retina poorly tolerant to persistent mitochondrial dysfunction and oxidative stress. Photobiomodulation (PBM), mainly based on red and near-infrared light, has been investigated as a way to support retinal cells that are functionally impaired but not yet irreversibly lost. The field has also acquired new clinical relevance after the 2024 De Novo marketing authorization by the United States Food and Drug Administration (FDA) of the Valeda Light Delivery System for dry age-related macular degeneration (AMD). This narrative review examines the mitochondrial, redox, inflammatory, and neurovascular mechanisms proposed for PBM, and discusses preclinical and clinical evidence across nonexudative AMD, inherited retinal degeneration, diabetic retinal disease, and light-induced damage. Current findings are encouraging, but devices, doses, schedules, endpoints, and sponsorship patterns differ substantially among studies. PBM therefore deserves further investigation, especially in early or intermediate disease, but its clinical use should remain linked to tested protocols, rigorous safety monitoring, and biomarkers of residual retinal functional reserve.<\/jats:p>","DOI":"10.3390\/antiox15081034","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:12:58Z","timestamp":1787155978000},"page":"1034","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Photobiomodulation for Photoreceptor Rescue in Retinal Disease: Mitochondrial, Redox, Vascular, and Translational Perspectives\u2014A Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7152-2613","authenticated-orcid":false,"given":"Mario D.","family":"Toro","sequence":"first","affiliation":[{"name":"Eye Clinic, Department of Public Health, University of Naples Federico II, 80131 Naples, Italy"},{"name":"Chair and Department of General and Paediatric Ophthalmology, Medical University of Lublin, 20-079 Lublin, Poland"},{"name":"Department of Special Surgery, University of Jordan, Queen Rania St., Amman 11942, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Avitabile","sequence":"additional","affiliation":[{"name":"Biomedicine, Neuroscience and Advanced Diagnostics (BIND) Department, University of Palermo, 90128 Palermo, Italy"},{"name":"Neurovisual Science Technology, Research Division (NEST-G.R.I.D.O.), 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Amato","sequence":"additional","affiliation":[{"name":"Neurovisual Science Technology, Research Division (NEST-G.R.I.D.O.), 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9577-2585","authenticated-orcid":false,"given":"Dario","family":"Rusciano","sequence":"additional","affiliation":[{"name":"Neurovisual Science Technology, Research Division (NEST-G.R.I.D.O.), 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8424-0068","authenticated-orcid":false,"given":"Caterina","family":"Gagliano","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Kore University of Enna, 94100 Enna, Italy"},{"name":"Mediterranean Foundation G.B. Morgagni, Ophthalmology Clinic, 95125 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","article-title":"The role of oxidative stress in the pathogenesis of age-related macular degeneration","volume":"45","author":"Beatty","year":"2000","journal-title":"Surv. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"publisher","first-page":"7836828","DOI":"10.1155\/2022\/7836828","article-title":"Role of oxidative stress in retinal disease and the early intervention strategies: A review","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.preteyeres.2017.03.002","article-title":"The impact of oxidative stress and inflammation on retinal pigment epithelium degeneration in non-neovascular age-related macular degeneration","volume":"60","author":"Datta","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.18240\/ijo.2016.01.24","article-title":"Photobiomodulation for the treatment of retinal diseases: A review","volume":"9","author":"Geneva","year":"2016","journal-title":"Int. J. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3934\/biophy.2017.3.337","article-title":"Mechanisms and applications of the anti-inflammatory effects of photobiomodulation","volume":"4","author":"Hamblin","year":"2017","journal-title":"AIMS Biophys."},{"key":"ref_6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/php.12864","article-title":"Mechanisms and mitochondrial redox signaling in photobiomodulation","volume":"94","author":"Hamblin","year":"2018","journal-title":"Photochem. Photobiol."},{"key":"ref_7","doi-asserted-by":"publisher","unstructured":"Desmettre, T., and Mordon, S. (2026). Photobiomodulation in age-related macular degeneration: A mitochondrial bioenergetic framework and translational perspective. Life, 16.","DOI":"10.3390\/life16071098"},{"key":"ref_8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res. Integr. Peer Rev."},{"key":"ref_9","doi-asserted-by":"publisher","first-page":"8428","DOI":"10.1167\/iovs.15-17901","article-title":"Quantification of oxygen consumption in retina ex vivo demonstrates limited reserve capacity of photoreceptor mitochondria","volume":"56","author":"Kooragayala","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev-vision-100419-115156","article-title":"Retina metabolism and metabolism in the pigmented epithelium: A busy intersection","volume":"7","author":"Hurley","year":"2021","journal-title":"Annu. Rev. Vis. Sci."},{"key":"ref_11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s42003-021-01765-3","article-title":"Photoreceptor metabolic reprogramming: Current understanding and therapeutic implications","volume":"4","author":"Pan","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_12","doi-asserted-by":"publisher","first-page":"e28899","DOI":"10.7554\/eLife.28899","article-title":"Biochemical adaptations of the retina and retinal pigment epithelium support a metabolic ecosystem in the vertebrate eye","volume":"6","author":"Kanow","year":"2017","journal-title":"eLife"},{"key":"ref_13","doi-asserted-by":"publisher","first-page":"100035","DOI":"10.1194\/jlr.TR120000618","article-title":"Fatty acid oxidation and photoreceptor metabolic needs","volume":"62","author":"Fu","year":"2021","journal-title":"J. Lipid Res."},{"key":"ref_14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.exer.2016.12.001","article-title":"NRF2 protects photoreceptor cells from photo-oxidative stress induced by blue light","volume":"154","author":"Chen","year":"2017","journal-title":"Exp. Eye Res."},{"key":"ref_15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41419-021-03660-5","article-title":"Mitochondrial quality control protects photoreceptors against oxidative stress in the H2O2-induced models of retinal degeneration diseases","volume":"12","author":"Zhou","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.preteyeres.2009.06.001","article-title":"Para-inflammation in the aging retina","volume":"28","author":"Xu","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_17","doi-asserted-by":"publisher","first-page":"11300","DOI":"10.1073\/pnas.0604056103","article-title":"Antioxidants reduce cone cell death in a model of retinitis pigmentosa","volume":"103","author":"Komeima","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/mt.2009.47","article-title":"Increased expression of catalase and superoxide dismutase 2 reduces cone cell death in retinitis pigmentosa","volume":"17","author":"Usui","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_19","doi-asserted-by":"publisher","first-page":"43603","DOI":"10.1155\/2007\/43603","article-title":"Oxidative stress and diabetic retinopathy","volume":"2007","author":"Kowluru","year":"2007","journal-title":"Exp. Diabetes Res."},{"key":"ref_20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.preteyeres.2009.11.004","article-title":"Retinal light damage: Mechanisms and protection","volume":"29","author":"Organisciak","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.preteyeres.2014.11.004","article-title":"Retinal microglia: Just bystander or target for therapy?","volume":"45","author":"Karlstetter","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/pho.2015.9848","article-title":"Low-level light\/laser therapy versus photobiomodulation therapy","volume":"33","author":"Anders","year":"2015","journal-title":"Photomed. Laser Surg."},{"key":"ref_23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s10439-011-0454-7","article-title":"The nuts and bolts of low-level laser (light) therapy","volume":"40","author":"Chung","year":"2012","journal-title":"Ann. Biomed. Eng."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2203\/dose-response.09-027.Hamblin","article-title":"Biphasic dose response in low level light therapy","volume":"7","author":"Huang","year":"2009","journal-title":"Dose Response"},{"key":"ref_25","unstructured":"(2014). Safety of Laser Products-Part 1: Equipment Classification and Requirements (Standard No. IEC 60825-1:2014)."},{"key":"ref_26","unstructured":"(2022). American National Standard for Safe Use of Lasers (Standard No. ANSI Z136.1-2022)."},{"key":"ref_27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaophthalmol.2023.1548","article-title":"Retinal damage after repeated low-level red-light laser exposure","volume":"141","author":"Liu","year":"2023","journal-title":"JAMA Ophthalmol."},{"key":"ref_28","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1074\/jbc.M409650200","article-title":"Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: Role of cytochrome c oxidase","volume":"280","author":"Liang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1109\/JSTQE.2016.2561201","article-title":"Proposed mechanisms of photobiomodulation or low-level light therapy","volume":"22","author":"Hamblin","year":"2016","journal-title":"IEEE J. Sel. Top. Quantum Electron."},{"key":"ref_30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1089\/photob.2020.4905","article-title":"What lies at the heart of photobiomodulation: Light, cytochrome c oxidase, and nitric oxide-review of the evidence","volume":"38","author":"Quirk","year":"2020","journal-title":"Photobiomodulation Photomed. Laser Surg."},{"key":"ref_31","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.neurobiolaging.2012.04.014","article-title":"Age-related retinal inflammation is reduced by 670 nm light via increased mitochondrial membrane potential","volume":"34","author":"Kokkinopoulos","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"ref_32","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/s41433-025-03805-2","article-title":"Photobiomodulation-induced choriocapillaris perfusion enhancement and outer retinal remodelling in intermediate age-related macular degeneration: A promising therapeutic approach with short-term results","volume":"39","author":"Viggiano","year":"2025","journal-title":"Eye"},{"key":"ref_33","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.21037\/atm.2019.01.43","article-title":"Mitochondrial cytochrome c oxidase is not the primary acceptor for near infrared light-it is mitochondrial bound water: The principles of low-level light therapy","volume":"7","author":"Sommer","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_34","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1073\/pnas.0534746100","article-title":"Therapeutic photobiomodulation for methanol-induced retinal toxicity","volume":"100","author":"Eells","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1167\/iovs.10-6664","article-title":"Photobiomodulation protects the retina from light-induced photoreceptor degeneration","volume":"52","author":"Albarracin","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.exer.2017.09.002","article-title":"Photobiomodulation with 670 nm light ameliorates M\u00fcller cell-mediated activation of microglia and macrophages in retinal degeneration","volume":"165","author":"Lu","year":"2017","journal-title":"Exp. Eye Res."},{"key":"ref_37","doi-asserted-by":"publisher","unstructured":"Heinig, N., Schumann, U., Calzia, D., Panfoli, I., Ader, M., Schmidt, M.H.H., Funk, R.H.W., and Roehlecke, C. (2020). Photobiomodulation mediates neuroprotection against blue light induced retinal photoreceptor degeneration. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072370"},{"key":"ref_38","doi-asserted-by":"publisher","first-page":"20382","DOI":"10.1038\/s41598-020-77290-w","article-title":"Photobiomodulation preserves mitochondrial redox state and is retinoprotective in a rodent model of retinitis pigmentosa","volume":"10","author":"Gopalakrishnan","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"publisher","unstructured":"Albarracin, R., Natoli, R., Rutar, M., Valter, K., and Provis, J. (2013). 670 nm light mitigates oxygen-induced degeneration in C57BL\/6J mouse retina. BMC Neurosci., 14.","DOI":"10.1186\/1471-2202-14-125"},{"key":"ref_40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2337\/db17-0803","article-title":"Photobiomodulation inhibits long-term structural and functional lesions of diabetic retinopathy","volume":"67","author":"Cheng","year":"2018","journal-title":"Diabetes"},{"key":"ref_41","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1111\/aos.13354","article-title":"Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age-related macular degeneration","volume":"95","author":"Merry","year":"2017","journal-title":"Acta Ophthalmol."},{"key":"ref_42","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1097\/IAE.0000000000002632","article-title":"A double-masked, randomized, sham-controlled, single-center study with photobiomodulation for the treatment of dry age-related macular degeneration","volume":"40","author":"Markowitz","year":"2020","journal-title":"Retina"},{"key":"ref_43","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s40123-022-00640-6","article-title":"LIGHTSITE II randomized multicenter trial: Evaluation of multiwavelength photobiomodulation in non-exudative age-related macular degeneration","volume":"12","author":"Burton","year":"2023","journal-title":"Ophthalmol. Ther."},{"key":"ref_44","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/IAE.0000000000003980","article-title":"LIGHTSITE III: 13-month efficacy and safety evaluation of multiwavelength photobiomodulation in nonexudative (dry) age-related macular degeneration using the LumiThera Valeda Light Delivery System","volume":"44","author":"Boyer","year":"2024","journal-title":"Retina"},{"key":"ref_45","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/IAE.0000000000004822","article-title":"Long-term efficacy and safety of photobiomodulation in dry age-related macular degeneration (LIGHTSITE III: 24-month analysis)","volume":"46","author":"Jaffe","year":"2026","journal-title":"Retina"},{"key":"ref_46","unstructured":"U.S. Food and Drug Administration (2026, July 25). Device Classification Under Section 513(f)(2)(De Novo): Valeda Light Delivery System (DEN230083), Available online: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/denovo.cfm?id=DEN230083."},{"key":"ref_47","doi-asserted-by":"publisher","unstructured":"Koss, M., and LIGHTSITE III Study Group (2025, January 15\u201317). LIGHTSITE IIIB: An open-label, prospective, multi-center extension study to assess the long-term safety and efficacy of photobiomodulation in subjects with dry age-related macular degeneration. Proceedings of the 37th International Congress of German Ophthalmic Surgery, N\u00fcrnberg, Germany.","DOI":"10.3205\/25doc010"},{"key":"ref_48","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s40123-025-01183-2","article-title":"Multiwavelength photobiomodulation improves multiple aspects of visual function in early-stage dry age-related macular degeneration","volume":"14","author":"Tedford","year":"2025","journal-title":"Ophthalmol. Ther."},{"key":"ref_49","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.oret.2021.10.003","article-title":"A randomized trial of photobiomodulation therapy for center-involved diabetic macular edema with good visual acuity (Protocol AE)","volume":"6","author":"Kim","year":"2022","journal-title":"Ophthalmol. Retin."},{"key":"ref_50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40135-025-00340-x","article-title":"Photobiomodulation therapy for management of retinal diseases","volume":"13","author":"Russell","year":"2025","journal-title":"Curr. Ophthalmol. Rep."},{"key":"ref_51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1001\/jamaophthalmol.2025.0077","article-title":"Photobiomodulation for age-related macular degeneration","volume":"143","author":"Sadda","year":"2025","journal-title":"JAMA Ophthalmol."},{"key":"ref_52","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature20587","article-title":"Gamma frequency entrainment attenuates amyloid load and modifies microglia","volume":"540","author":"Iaccarino","year":"2016","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/s41596-018-0021-x","article-title":"Noninvasive 40-Hz light flicker to recruit microglia and reduce amyloid beta load","volume":"13","author":"Singer","year":"2018","journal-title":"Nat. Protoc."},{"key":"ref_54","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/joim.13329","article-title":"Induction of specific brain oscillations may restore neural circuits and be used for the treatment of Alzheimer\u2019s disease","volume":"290","author":"Chan","year":"2021","journal-title":"J. Intern. Med."},{"key":"ref_55","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/joim.13755","article-title":"Audiovisual gamma stimulation for the treatment of neurodegeneration","volume":"295","author":"Chan","year":"2024","journal-title":"J. Intern. Med."},{"key":"ref_56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-024-07132-6","article-title":"Multisensory gamma stimulation promotes glymphatic clearance of amyloid","volume":"627","author":"Murdock","year":"2024","journal-title":"Nature"},{"key":"ref_57","doi-asserted-by":"publisher","first-page":"e70792","DOI":"10.1002\/alz.70792","article-title":"Gamma sensory stimulation in mild Alzheimer\u2019s dementia: An open-label extension study","volume":"21","author":"Chan","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_58","doi-asserted-by":"publisher","unstructured":"Age-Related Eye Disease Study Research Group (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8. Arch. Ophthalmol., 119, 1417\u20131436.","DOI":"10.1001\/archopht.119.10.1417"},{"key":"ref_59","doi-asserted-by":"publisher","unstructured":"Age-Related Eye Disease Study 2 Research Group (2013). Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 randomized clinical trial. JAMA, 309, 2005\u20132015.","DOI":"10.1001\/jama.2013.4997"},{"key":"ref_60","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): Two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"key":"ref_61","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"key":"ref_62","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1089\/pho.2011.9895","article-title":"How to report low-level laser therapy (LLLT)\/photomedicine dose and beam parameters in clinical and laboratory studies","volume":"29","author":"Jenkins","year":"2011","journal-title":"Photomed. Laser Surg."},{"key":"ref_63","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1039\/C8PP00176F","article-title":"Photobiomodulation: Lasers vs. light emitting diodes?","volume":"17","author":"Heiskanen","year":"2018","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7326\/M17-0046","article-title":"CONSORT Statement for randomized trials of nonpharmacologic treatments: A 2017 update and a CONSORT extension for nonpharmacologic trial abstracts","volume":"167","author":"Boutron","year":"2017","journal-title":"Ann. Intern. Med."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/8\/1034\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:14:52Z","timestamp":1787156092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/8\/1034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":64,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["antiox15081034"],"URL":"https:\/\/doi.org\/10.3390\/antiox15081034","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]}}}